Trial Profile
Controlled Study of ONO-5920 in Patients With Involutional Osteoporosis in Japan
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 06 Jun 2016
Price :
$35
*
At a glance
- Drugs Minodronic acid (Primary)
- Indications Osteoporosis
- Focus Therapeutic Use
- Sponsors Ono Pharmaceutical
- 06 Jun 2016 New trial record
- 06 Jun 2016 New trial record